United Kingdom (UK) mRNA Therapeutics Market (2025-2031) | Growth, Segmentation, Industry, Competitive Landscape, Size & Revenue, Forecast, Companies, Share, Analysis, Outlook, Value, Trends

Market Forecast By Type (Prophylactic, Therapeutic), By Application (Infectious Diseases, Oncology, Rare Genetic Diseases, Respiratory Diseases, Others), By End use (Hospitals & Clinics, Research Organizations, Others) And Competitive Landscape
Product Code: ETC9958281 Publication Date: Sep 2024 Updated Date: Aug 2025 Product Type: Market Research Report
Publisher: 6Wresearch Author: Dhaval Chaurasia No. of Pages: 75 No. of Figures: 35 No. of Tables: 20

Key Highlights of the Report:

  • United Kingdom (UK) mRNA Therapeutics Market Outlook
  • Market Size of United Kingdom (UK) mRNA Therapeutics Market, 2024
  • Forecast of United Kingdom (UK) mRNA Therapeutics Market, 2031
  • Historical Data and Forecast of United Kingdom (UK) mRNA Therapeutics Revenues & Volume for the Period 2021- 2031
  • United Kingdom (UK) mRNA Therapeutics Market Trend Evolution
  • United Kingdom (UK) mRNA Therapeutics Market Drivers and Challenges
  • United Kingdom (UK) mRNA Therapeutics Price Trends
  • United Kingdom (UK) mRNA Therapeutics Porter's Five Forces
  • United Kingdom (UK) mRNA Therapeutics Industry Life Cycle
  • Historical Data and Forecast of United Kingdom (UK) mRNA Therapeutics Market Revenues & Volume By Type for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) mRNA Therapeutics Market Revenues & Volume By Prophylactic for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) mRNA Therapeutics Market Revenues & Volume By Therapeutic for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) mRNA Therapeutics Market Revenues & Volume By Application for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) mRNA Therapeutics Market Revenues & Volume By Infectious Diseases for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) mRNA Therapeutics Market Revenues & Volume By Oncology for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) mRNA Therapeutics Market Revenues & Volume By Rare Genetic Diseases for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) mRNA Therapeutics Market Revenues & Volume By Respiratory Diseases for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) mRNA Therapeutics Market Revenues & Volume By Others for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) mRNA Therapeutics Market Revenues & Volume By End use for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) mRNA Therapeutics Market Revenues & Volume By Hospitals & Clinics for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) mRNA Therapeutics Market Revenues & Volume By Research Organizations for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) mRNA Therapeutics Market Revenues & Volume By Others for the Period 2021- 2031
  • United Kingdom (UK) mRNA Therapeutics Import Export Trade Statistics
  • Market Opportunity Assessment By Type
  • Market Opportunity Assessment By Application
  • Market Opportunity Assessment By End use
  • United Kingdom (UK) mRNA Therapeutics Top Companies Market Share
  • United Kingdom (UK) mRNA Therapeutics Competitive Benchmarking By Technical and Operational Parameters
  • United Kingdom (UK) mRNA Therapeutics Company Profiles
  • United Kingdom (UK) mRNA Therapeutics Key Strategic Recommendations

Frequently Asked Questions About the Market Study (FAQs):

6Wresearch actively monitors the United Kingdom (UK) mRNA Therapeutics Market and publishes its comprehensive annual report, highlighting emerging trends, growth drivers, revenue analysis, and forecast outlook. Our insights help businesses to make data-backed strategic decisions with ongoing market dynamics. Our analysts track relevent industries related to the United Kingdom (UK) mRNA Therapeutics Market, allowing our clients with actionable intelligence and reliable forecasts tailored to emerging regional needs.
Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on sales@6wresearch.com

1 Executive Summary

2 Introduction

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3 United Kingdom (UK) mRNA Therapeutics Market Overview

3.1 United Kingdom (UK) Country Macro Economic Indicators

3.2 United Kingdom (UK) mRNA Therapeutics Market Revenues & Volume, 2021 & 2031F

3.3 United Kingdom (UK) mRNA Therapeutics Market - Industry Life Cycle

3.4 United Kingdom (UK) mRNA Therapeutics Market - Porter's Five Forces

3.5 United Kingdom (UK) mRNA Therapeutics Market Revenues & Volume Share, By Type, 2021 & 2031F

3.6 United Kingdom (UK) mRNA Therapeutics Market Revenues & Volume Share, By Application, 2021 & 2031F

3.7 United Kingdom (UK) mRNA Therapeutics Market Revenues & Volume Share, By End use, 2021 & 2031F

4 United Kingdom (UK) mRNA Therapeutics Market Dynamics

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing prevalence of genetic disorders and chronic diseases in the UK

4.2.2 Growing investments in research and development of mRNA therapeutics

4.2.3 Favorable regulatory environment supporting the development and commercialization of mRNA therapies

4.3 Market Restraints

4.3.1 High cost associated with mRNA therapeutics development and production

4.3.2 Limited awareness and acceptance of mRNA therapeutics among healthcare professionals and patients in the UK

5 United Kingdom (UK) mRNA Therapeutics Market Trends

6 United Kingdom (UK) mRNA Therapeutics Market, By Types

6.1 United Kingdom (UK) mRNA Therapeutics Market, By Type

6.1.1 Overview and Analysis

6.1.2 United Kingdom (UK) mRNA Therapeutics Market Revenues & Volume, By Type, 2021- 2031F

6.1.3 United Kingdom (UK) mRNA Therapeutics Market Revenues & Volume, By Prophylactic, 2021- 2031F

6.1.4 United Kingdom (UK) mRNA Therapeutics Market Revenues & Volume, By Therapeutic, 2021- 2031F

6.2 United Kingdom (UK) mRNA Therapeutics Market, By Application

6.2.1 Overview and Analysis

6.2.2 United Kingdom (UK) mRNA Therapeutics Market Revenues & Volume, By Infectious Diseases, 2021- 2031F

6.2.3 United Kingdom (UK) mRNA Therapeutics Market Revenues & Volume, By Oncology, 2021- 2031F

6.2.4 United Kingdom (UK) mRNA Therapeutics Market Revenues & Volume, By Rare Genetic Diseases, 2021- 2031F

6.2.5 United Kingdom (UK) mRNA Therapeutics Market Revenues & Volume, By Respiratory Diseases, 2021- 2031F

6.2.6 United Kingdom (UK) mRNA Therapeutics Market Revenues & Volume, By Others, 2021- 2031F

6.3 United Kingdom (UK) mRNA Therapeutics Market, By End use

6.3.1 Overview and Analysis

6.3.2 United Kingdom (UK) mRNA Therapeutics Market Revenues & Volume, By Hospitals & Clinics, 2021- 2031F

6.3.3 United Kingdom (UK) mRNA Therapeutics Market Revenues & Volume, By Research Organizations, 2021- 2031F

6.3.4 United Kingdom (UK) mRNA Therapeutics Market Revenues & Volume, By Others, 2021- 2031F

7 United Kingdom (UK) mRNA Therapeutics Market Import-Export Trade Statistics

7.1 United Kingdom (UK) mRNA Therapeutics Market Export to Major Countries

7.2 United Kingdom (UK) mRNA Therapeutics Market Imports from Major Countries

8 United Kingdom (UK) mRNA Therapeutics Market Key Performance Indicators

8.1 Number of clinical trials involving mRNA therapeutics conducted in the UK

8.2 Rate of adoption of mRNA therapies by healthcare providers in the UK

8.3 Percentage of investment in mRNA therapeutics research compared to overall pharmaceutical research and development spending in the UK

9 United Kingdom (UK) mRNA Therapeutics Market - Opportunity Assessment

9.1 United Kingdom (UK) mRNA Therapeutics Market Opportunity Assessment, By Type, 2021 & 2031F

9.2 United Kingdom (UK) mRNA Therapeutics Market Opportunity Assessment, By Application, 2021 & 2031F

9.3 United Kingdom (UK) mRNA Therapeutics Market Opportunity Assessment, By End use, 2021 & 2031F

10 United Kingdom (UK) mRNA Therapeutics Market - Competitive Landscape

10.1 United Kingdom (UK) mRNA Therapeutics Market Revenue Share, By Companies, 2024

10.2 United Kingdom (UK) mRNA Therapeutics Market Competitive Benchmarking, By Operating and Technical Parameters

11 Company Profiles

12 Recommendations

13 Disclaimer

Pricing
  • Single User License
    $ 1,995
  • Department License
    $ 2,400
  • Site License
    $ 3,120
  • Global License
    $ 3,795
6Wresearch Support

Any Query

Call: +91-11-4302-4305
Email us: sales@6wresearch.com
Any Query? Click Here

Thought Leadership and Analyst Meet

Our Clients

Airtel
Canon
Contec
HoneyWell
Kriloskar
Pwc Logo
Samsung
Tata Teleservices

Related Reports

Industry Events and Analyst Meet

Whitepaper

Read All